rs3024801

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000542.5(SFTPB):​c.526C>T​(p.Leu176Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000497 in 1,614,180 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 2 hom. )

Consequence

SFTPB
NM_000542.5 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0490

Publications

9 publications found
Variant links:
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]
SFTPB Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003846556).
BP6
Variant 2-85665662-G-A is Benign according to our data. Variant chr2-85665662-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 596954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00234 (357/152344) while in subpopulation AFR AF = 0.00786 (327/41580). AF 95% confidence interval is 0.00716. There are 1 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPBNM_000542.5 linkc.526C>T p.Leu176Phe missense_variant Exon 5 of 11 ENST00000519937.7 NP_000533.4 P07988D6W5L6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPBENST00000519937.7 linkc.526C>T p.Leu176Phe missense_variant Exon 5 of 11 1 NM_000542.5 ENSP00000428719.2 P07988
SFTPBENST00000393822.7 linkc.526C>T p.Leu176Phe missense_variant Exon 6 of 12 1 ENSP00000377409.4 P07988
SFTPBENST00000409383.7 linkc.526C>T p.Leu176Phe missense_variant Exon 6 of 12 1 ENSP00000386346.2 P07988
SFTPBENST00000428225.5 linkc.514C>T p.Leu172Phe missense_variant Exon 5 of 11 2 ENSP00000415347.1 H0Y7V6

Frequencies

GnomAD3 genomes
AF:
0.00234
AC:
356
AN:
152226
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00786
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000654
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000705
AC:
177
AN:
251166
AF XY:
0.000493
show subpopulations
Gnomad AFR exome
AF:
0.00779
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00218
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000305
AC:
446
AN:
1461836
Hom.:
2
Cov.:
32
AF XY:
0.000282
AC XY:
205
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.00750
AC:
251
AN:
33478
American (AMR)
AF:
0.000380
AC:
17
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00195
AC:
51
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86254
European-Finnish (FIN)
AF:
0.000449
AC:
24
AN:
53412
Middle Eastern (MID)
AF:
0.00314
AC:
18
AN:
5732
European-Non Finnish (NFE)
AF:
0.0000351
AC:
39
AN:
1112008
Other (OTH)
AF:
0.000712
AC:
43
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00234
AC:
357
AN:
152344
Hom.:
1
Cov.:
32
AF XY:
0.00215
AC XY:
160
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00786
AC:
327
AN:
41580
American (AMR)
AF:
0.000653
AC:
10
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68034
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000877
Hom.:
1
Bravo
AF:
0.00258
ESP6500AA
AF:
0.00817
AC:
36
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000923
AC:
112
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SFTPB: BP4, BS2 -

not specified Benign:1
May 07, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SFTPB-related disorder Benign:1
Jul 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hereditary pulmonary alveolar proteinosis Benign:1
Nov 25, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Surfactant metabolism dysfunction, pulmonary, 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
14
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T;T;T
Eigen
Benign
0.024
Eigen_PC
Benign
-0.071
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.75
.;T;T
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.0038
T;T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Uncertain
2.3
M;M;.
PhyloP100
0.049
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-0.54
.;N;N
REVEL
Benign
0.19
Sift
Benign
0.038
.;D;D
Sift4G
Uncertain
0.011
D;D;D
Polyphen
0.99
D;D;D
Vest4
0.30
MVP
0.85
MPC
0.90
ClinPred
0.031
T
GERP RS
4.0
Varity_R
0.11
gMVP
0.37
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024801; hg19: chr2-85892785; API